Search research articles
Contact Us
Filters
Showing results (141-150 of 275) with videos related to
Page
of 28
Sort By:
Pharmacogenetics
|
October 1, 1992
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
A Rautio, H Kraul, A Kojo, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
cAMP mediated upregulation of CYP2A5 in mouse hepatocytes
P Viitala, K Posti, A Lindfors, et al.
Biochemical and Biophysical Research Communications
|
December 21, 1977
Effects of harman and norharman on the mutagenicity and binding to DNA of benzo[a]pyrene metabolites in vitro and on aryl hydrocarbon hydroxylase induction in cell culture
R C Levitt, C Legraverend, D W Nebert, et al.
Scandinavian Journal of Work, Environment & Health
|
September 1, 1976
A study on the mutagenic activity of styrene and styrene oxide
H Vainio, R Pääkkönen, K Rönnholm, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1997
Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions
E A Sotaniemi, A J Arranto, O Pelkonen, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
H I Pirttiaho, E A Sotaniemi, R O Pelkonen, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1981
Aryl hydrocarbon hydroxylase induction in maternal and cord blood mitrogen-treated lymphocytes
N T Kärki, O Pelkonen, R Tuimala, et al.
Toxicology
|
February 27, 2003
Accumulation of silver from drinking water into cerebellum and musculus soleus in mice
Kai H O Pelkonen, Helvi Heinonen-Tanski, Osmo O P Hänninen
British Journal of Clinical Pharmacology
|
January 1, 1995
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients
E A Sotaniemi, A Rautio, M Bäckstrom, et al.
Pharmacology & Toxicology
|
May 1, 1988
Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities
M Pasanen, T Taskinen, E A Sotaniemi, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 275) with videos related to
Sort By:
Page
of 28
Pharmacogenetics
|
October 1, 1992
Interindividual variability of coumarin 7-hydroxylation in healthy volunteers
A Rautio, H Kraul, A Kojo, et al.
Biochemical and Biophysical Research Communications
|
February 13, 2001
cAMP mediated upregulation of CYP2A5 in mouse hepatocytes
P Viitala, K Posti, A Lindfors, et al.
Biochemical and Biophysical Research Communications
|
December 21, 1977
Effects of harman and norharman on the mutagenicity and binding to DNA of benzo[a]pyrene metabolites in vitro and on aryl hydrocarbon hydroxylase induction in cell culture
R C Levitt, C Legraverend, D W Nebert, et al.
Scandinavian Journal of Work, Environment & Health
|
September 1, 1976
A study on the mutagenic activity of styrene and styrene oxide
H Vainio, R Pääkkönen, K Rönnholm, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1997
Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions
E A Sotaniemi, A J Arranto, O Pelkonen, et al.
European Journal of Clinical Pharmacology
|
January 1, 1982
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
H I Pirttiaho, E A Sotaniemi, R O Pelkonen, et al.
Developmental Pharmacology and Therapeutics
|
January 1, 1981
Aryl hydrocarbon hydroxylase induction in maternal and cord blood mitrogen-treated lymphocytes
N T Kärki, O Pelkonen, R Tuimala, et al.
Toxicology
|
February 27, 2003
Accumulation of silver from drinking water into cerebellum and musculus soleus in mice
Kai H O Pelkonen, Helvi Heinonen-Tanski, Osmo O P Hänninen
British Journal of Clinical Pharmacology
|
January 1, 1995
CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients
E A Sotaniemi, A Rautio, M Bäckstrom, et al.
Pharmacology & Toxicology
|
May 1, 1988
Inhibitor panel studies of human hepatic and placental cytochrome P-450-associated monooxygenase activities
M Pasanen, T Taskinen, E A Sotaniemi, et al.
Page
of 28